Diabetes and bone: Advantages and limitations of radiological, radionuclide and hybrid techniques in the assessment of diabetic foot

Minerva Endocrinologica

Volumn 34, Issue 3, 2009, Pages 237-254

  Gnanasegaran, G ^a   Chicklore, S ^a   Vijayanathan, S ^a   O'Doherty, M J ^a   Fogelman, I ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetes complications; Diabetic foot; Soft tissue infections; Technology, radiologic

Indexed keywords

FANOLESOMAB TC 99M; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEUKOCYTE IN 111; MEDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BONE SCINTISCANNING; DIABETES MELLITUS; DIABETIC FOOT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FOOT RADIOGRAPHY; HUMAN; JOINT RADIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOFT TISSUE INFECTION; BONE; BONE DISEASE; RADIOGRAPHY; SCINTISCANNING;

BONE AND BONES; BONE DISEASES; DIABETES COMPLICATIONS; DIABETIC FOOT; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77949906558     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clinical Infectious Diseases 2008;47:519-27.
2. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288-3.
3. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-28. (Pubitemid 40095873)
4. Tomas MB, Patel M, Marvin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000;73:443-50
5. Love C, Tomas M, Tronco G, Palestro CJ. FDG PET of Infection and Inflammation. RadioGraphics 2005;25:1357-68.
6. Love C, Palestro CJ. Radionuclide Imaging of Infection. J Nucl Med Technol 2004;32:47-57
7. Marcus CD, Ladam-Marcus VJ, Leone J, Malgrange D, Bonnet-Gausserand FM, Menanteau BP. MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics. 1996;16:1337-48. (Pubitemid 126448185)
8. Bader MS. Diabetic foot infection. Am Fam Physician 2008;1;78:71-9
9. Tehranzadeh J, Wong E, Wang F, Sadighpour M. Imaging of osteomyelitis in the mature skeleton. Radiol Clin North Am 2001;39:223-50
10. Edmonds ME Progress in care of the diabetic foot. Lancet 1999;354:270-2.
11. Schumacher JR HR. Secondary osteoarthritis. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, editors. Osteoarthritis: diagnosis and management Philadelphia, PA: WB Saunders; 1984. P. 234-64.
12. Edmonds ME, Watkins PJ Plantar Neuropathic ulcers and Charcot joints: risk factors, presentation, and management In: Dyck PJ, Thomas PK, editors. Diabetic neuropathy. Philadelphia: W B Saunders; 1999. p. 398-406.
13. Frykberg RG, Kozak GP ,Neuropathic arthropathy in the diabetic foot. Am Fam Physician 1978, 17:105-13.
14. Wilson M. Charcot foot osteoarthropathy in diabetes mellitus. Mil Med 1991;156:563-9.
15. Berenyi MR, Siegel MW, Schwarz GS. Arthropathy of the wrist in a patient with diabetic neuritis. J Am Geriatr Soc 1968;16:826-31.
16. Bayne O, Lu EJ. Diabetic Charcot's arthropathy of the wrist. Case report and literature review. Clinical Orthop 1998;357:122-6.
17. Lambert AP, Close CF Knee neuroarthropathy in a patient with type I diabetes. Diabet Med 1998;15:S12.
18. Berg EE. Charcot arthropathy after acetabular fracture. J Bone Joint Surg Br 1997;79:742-5.
19. Phillips S, Williams AL, Peters JR , Neuropathic arthropathy of the spine in diabetes. Diabetes Care 1995;18:867-9.
20. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G et al. Unsus-pected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA 1991;266:1246-51.
21. Butalia S, Palda VA, Sargeant RJ, Detsky AS, Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA 2008;299:806-13.
22. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2(2):64-122.
23. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997;27:334-45.
24. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections.Semin Nucl Med 2009;39:52-65.
25. Termaat MF, Raijmakers PGHM, Scholten HJ, Bakker FC, Patka P, Haarman HJTM. A systematic review and meta-analysis the accuracy of diagnostic imaging for the assessment of chronic osteomyelitis. J Bone Joint Surg Am 2005;87:2464-24.
26. Kaim AH, Gross T, von Schulthess GK. Imaging of chronic posttraumatic os- teomyelitis. Eur Radiol 2002;12:1193-202.
27. Gross T, Kaim AH, Regazzoni P, Widmer AF. Current concepts in posttraumatic osteomyelitis: a diagnostic challenge with new imaging options. J Trauma 2002;52:1210-9.
28. Oudjhane K, Azouz EM. Imaging of osteomyelitis in children, Radiol Clin North Am 2001;39:251-66.
29. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. Acute hematogenous osteomyelitis of children: assessment of skeletal scintigraphy-based diagnosis in the era of MRI. J Nucl Med 2002;43:1310-6.
30. Jaramillo D, Treves ST, Kasser JR, Harper M, Sundel R, Laor T. Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment. AJR Am J Roentgenol 1995;165:399-403.
31. Seabold JE, Flickinger FW, Kao SCS et al. Indium-111-Leukocyte/ Technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med 1990: 31:549-56.
32. Giurini JM, Chrzan JS, Gibbons GW, Habershaw GM Charcot's disease in diabetic patients. Postgrad Med 1991;89:163-9.
33. Llauger J, Palmer J, Roson N, Bague S, Camins A, Cremades R. Nonseptic monoarthritis: imaging features with clinical and histopathologic correlation. Radiographics 2000;20:S263-5278.
34. Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc 2002;92:210-20.
35. Eichenholtz SN. Charcot joints. Springfield, IL: Charles C Thomas; 1966.
36. Gold RH, Tong MD, Crim JR, Seeger LL, Imaging the diabetic foot. Skeletal Radiol 1995;24:563-71.
37. Erdman WA, Tamburro F, Jayson HT, Weatherall PT, Ferry KB, Peshock RM. Osteomyelitis: characteristics and pitfalls of diagnosis with MR imaging. Radiology 1991;180:533-9.
38. Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg 2003;20:729-40.
39. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am 2002;40:1171-92.
40. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;45:1085-96.
41. Palestro CJ, Mehta HH, Patel M, Freeman SJ, Harrington WN, Tomas MB et al. Marrow versus infection in Charcot joint: Indium-111 leukocyte and technetium-99m sulphur colloid scintigraphy. J Nucl Med 1998;39:346-50. (Pubitemid 28114530)
42. Lipman BT, Collier BD, Carrera GF, Timins ME, Erickson SJ, Johnson JE et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. Clin Nucl Med 1988;23:77-82.
43. Sartoris DJ Cross-sectional imaging of the diabetic foot. J Foot Ankle Surg 1994;33:531-45.
44. Deely DM, Schweitzer ME. MR imaging of bone marrow disorders. Radiol Clin North Am 1997;35:193-212.
45. Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996;17:10-6.
46. Schweitzer ME, Daffner RH, Weissman BN, Bennett DL, Blebea JS, Jacobson JA et al. ACR Appropriateness Criteria® on Suspected Osteomyelitis in Patients With Diabetes Mellitus J Am Coll Radiol 2008;5:881-6.
47. Tan L, Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol 2007;80:939-48. (Pubitemid 350206225)
48. Wrobel JS, Connolly JE. Making the diagnosis of osteomyelitis: the role of prevalence. J Am Podiatr Med Assoc 1998;88:337-43.
49. Morrison WB, Schweitzer ME, Batte WG, Radack DP, Russel KM. Osteomyelitis of the foot: relative importance of primary and secondaryMR imaging signs. Radiology 1998;207:625-32.
50. Morrison WB, Schweitzer ME, Bock GW, Mitchell DG, Hume EL, Pathria MN. Diagnosis of osteomyelitis: utility of fatsuppressed contrast-enhanced MR imaging. Radiology 1993;189:251-7.
51. Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA et al. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology 1997;203:849-55. (Pubitemid 27227441)
52. Weinstein D, Wang A, Chambers R, Stewart CA, Motz HA. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Foot Ankle 1993;14:18-22. (Pubitemid 23075119)
53. Beltran J, Campanini DS, Knight C, McCalla M. The diabetic foot: magnetic resonance imaging evaluation. Skeletal Radiol 1990;19:37-41. (Pubitemid 20039761)
54. Ledermann HP, Morrison WB, Schweitzer ME. MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis. Radiology 2002;223:747-55.
55. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am. 2002;40:1171-92.
56. Myerson MS, Alvarez RG, Lam PW, Tibiocalcaneal arthrodesis for the management of severe ankle and hindfoot deformities. Foot Ankle Int 2000;21:643-50.
57. Yuh WT, Corson JD, Baraniewski HM, Rezai K, Shamma AR, Kathol MH et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain ?lm, 99mTc-MDP bone scintigraphy, and MR imaging. AJR Am J Roentgenol 1989;152:795-800.
58. Beltran J, Campanini DS, Knight C, McCalla M. The diabetic foot: magnetic resonance imaging evaluation. Skeletal Radiol 1990;19:37-41. (Pubitemid 20039761)
59. Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology 2006;238:622-31.
60. Becker W. Imaging osteomyelitis and the diabetic foot. Q J Nucl Med 1999;43:9-20.
61. Turpin S, Lambert R. Role of scintigraphy in musculoskeletal and spinal infections. Radiol Clin North Am 2001;39:169-89. (Pubitemid 32295240)
62. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis AJR AmJ Roentgenol 1992;158:9-18.
63. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989;149:2262-66. (Pubitemid 19258171)
64. Larcos G, Brown ML, Sutton R. Diagnosis of osteomyelitis of the foot in diabetic patients: Value of 111In-leukocyte scintigraphy. AJR Am J Roentgenol 1991;157:527-31.
65. Maurer AH, Millmond SH, Knight LC, Mesgarzadeh M, Siegel JA, Shuman CR et al. Infection in diabetic osteo- arthropathy: Use of indium-labeled leukocytes for diagnosis. Radiology 1986;151:221-5.
66. Devillers A, Moissan A, Hennion F, Garin E, Poirier JY, Bourguet Pl. Contribution of technetium- 99m hexamethylpropylene amine oxime labeled leucocyte scintigra- phy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998; 25:132-8.
67. Harvey J, Cohen MM: Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. J Foot Ankle Surg1997;36:209-14.
68. Blume PA, Dey HM, Dailey LJ, Arrighi JA, Soufer R, Gorecki GA. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. J Foot Ankle Surg 1997;36:120-6. (Pubitemid 27183768)
69. Love C, Din AS, Tomas MB, Kalapparambath TP, Palestro CJ. Radionuclide bone imaging: an illustrative review. Radiographics 2003;23:341-58. (Pubitemid 37431266)
70. Peters AM. Nuclear medicine imaging in infection and inflammation. J R Coll Physicians Lond 1998;32:512-9.
71. Love C, Patel M, Lonner BS, Tomas MB, Palestro CJ. Diagnosing spinal osteomyelitis: a comparison of bone and Ga-67 scintigraphy and magnetic resonance imaging. Clin Nucl Med 2000;25:963-77.
72. Palestro CJ, Tomas MB. Scintigraphic evaluation of the diabetic foot. In: Freeman LM, ed. Nuclear Medicine Annual 2000. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:143-72.
73. Hughes DK. Nuclear Medicine and Infection Detection: The Relative Effectiveness of Imaging with 111 In-Oxine-, 99mTc-HMPAO-, and 99m Tc-Stannous Fluoride Colloid-Labeled Leukocytes and with 67Ga-Citrate J Nucl Med Technol 2003;31:196-201.
74. Solanki K, BomanjiJ, Siraj Q, Small M, Britton K. Tc-99m-Infecton:a new class of radiopharmaceutical for imaging infection. J Nucl Med 1993;34(Suppl):119P.
75. Sonmezoglu K, Sonmezoglu M, Halac M, Akgun I, Turkmen C, Onsel C et al. Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopaedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med 2001;42:567-74. (Pubitemid 32298275)
76. Thakur ML, Richard MD, White FW III. Monoclonal antibodies as agents for selective radiolabeling of human neutrophils. J Nucl Med 1988;29:1817-25.
77. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002;32:47-59. (Pubitemid 34112942)
78. Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O, The diabetic foot: initial experience with 18F-FDG PET/CTJ Nucl Med 2005;46:444-9.
79. th edition. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 429-63.
80. Graham GD, Lundy MM, Moreno AJ, Frederick RJ. The role of Tc-99m MDP and Ga-67 citrate in predicting the cure of osteomyelitis. Clin Nucl Med 1983;8:344-6.
81. Edmonds ME, Clarke MB, Newton S, Barrett J, Watkins PJ. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. QJM 1985;57:843. (Pubitemid 16179090)
82. Gough A, Abraha H, Li F, Purewal TS, Foster AV, Watkins PJ. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med 1997;14:527. (Pubitemid 27298811)
83. th edition. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 1205-19.
84. Lewin JS, Rosenfield NS, Hoffer PB, Downing D. Acute osteomyelitis in children: combined Tc-99m and Ga-67 imaging. Radiology 1986,158:795-804. (Pubitemid 16101279)
85. Hadjipavlou AG, Cesani-Vazquez F, Villaneuva-MeyerJ, MaderJT, Necessary JT, Crow W et al. The effectiveness of gallium citrate Ga 67 radionuclide imaging in vertebral osteomyelitis revisited. AmJ Orthop 1998;27:179-83.
86. Al Sheikh W, Sfakianakis GN, Mnaymneh W, Hourani M, Heal A, Duncan RC et al. Suhacute and chronic bone infections: diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy, and radiography. Radiology 1985;155:501-6. (Pubitemid 15033146)
87. Gratz S, Dorner J, Oestmann JW, Opitz M, Behr T, Meiler J et al. 67Ga-citrate and 99mTc-MDP for estimating the severity of vertebral osteomyelitis. Nucl Med Commun 2000;21:111-20.
88. nd edition. Edinburgh: Churchill Livingstone; 1998. p. 1185-207.
89. Rosenthall L, Kloiher R, Damtew B, Al Majid H. Sequential use of radiophosphate and radiogallium imaging in the differential diagnosis of bone, joint and sort tissue infection: quantitative analysis. Diagn Imaging 1982;51:249-58. (Pubitemid 12053238)
90. Guze BH, Webher MM, Hawkins RA, Sinha K. Indium-111 white blood cell scans: sensitivity, specificity, accuracy, and normal patterns of distribution. Clin Nucl Med 1990;15:8-10. (Pubitemid 20085596)
91. Raptopoulos V, Doherty PW, Goss TP, King MA, Johnson K, Gantz NM. Acute osteomyelitis: advantage of white cell scans in early detection. AJR AmJ Roentgenol 1982;139:1077-82. (Pubitemid 13201954)
92. Schauwecker DS. Osteomyelitis. Diagnosis with In-111-labeled leukocytes. Radiology 1989;171:141-6.
93. Santiago Restrepo C, Gimenez CR, McCarthy K. Imaging of osteomyelitis and musculoskeletal soft tissue infections: current concepts. Rheum Dis Clin North Am 2003;29:89-109. (Pubitemid 36298105)
94. Palestro CJ, Kipper SL, Weiland FL, Love C, Tomas MB. Osteomyelitis: diagnosis with 99mTc-labeled anti-granulocyte antibodies compared with diagnosis with indium-111-labeled leukocytes - initial experience. Radiology 2002;223:758-64.
95. Datz FL, Thorne DA. Effect of antibiotic therapy on the sensitivity of indium-111-labeled leukocyte scans. J Nucl Med 1986;27:1849-53.
96. McllcrJ, Koster G, Liersch T, Siefker U, Lehmann K, Meyer I et al. Chronic bacterial osteomyelitis: prospective comparison of 18F-FDG imaging with a dual-head coincidence camera and 111In-labeled autologous leucocyte scintigraphy. Eur J Nucl Med Mol Imaging 2002;29:53-60.
97. Becker W, Schomann E, Fischbach W, Borner W, Gruner KR. Comparison of 99mTc-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results. Nucl Med Commun 1988;9:435-47.
98. Wolf G, Aigner RM, Schwarz T. Diagnosis of bone infection using 99mTc-HMPAO labelled leukocytes. Nucl Med Commun 2001;22:1201-6.
99. Poirier JY, Garin E, Derrien C, Devillers A, Moisan A, Bourguet P et al. Diagnosis of osteomyelitis in the diabetic foot with a 99mTc HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab 2002;28(6 Pt 1):485-90.
100. Schauwecker DS, Park HM, Burt RW, Mock BH, Wellman HN. combined bone scintigraphy and indium-11 leukocyte scans in neuropathic foot disease. J Nucl Med 1988;29:1651-5.
101. Remedios D, Valabjhii J, Oelbaum R, Sharp P, Mitchell R. 99m Tc-nanocolloid scintography for assessing osteomyelitis in diabetic neuropathic feet. Clin Radiol 1998;53:120-5.
102. Maugendre D, Poirier JY. Nuclear medicine in the diagnosis of diabetic foot osteomyelitis. Diabetes Metab 2001;27:396-400.
103. El-Maghraby TAF, Moustafa HM, Pauwels EKJ. Q J Nucl Med Mol Imaging 2006;50:167-92.
104. Sarda L, Cremieux AC Lebellec Y, Meulemans A, Lebtahi R, Hayem G et al. Inability of "'"Tc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 2003;44:920-6.
105. De Winter F, Gemmel F, Van Laere K, De Winter O, Poffijn B, Dierckx RA et al. Tc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine:experience in 48 patients. EurJ Nucl Med Mol Imaging 2004;31:233-9.
106. Appelboom T, Emery P, Tant L, Dumarey N, Schoutens A. Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatology (Oxford) 2003;42:1179-82.
107. Langer O, Brunner M, Zeitlinger M, Ziegler S, Muller U, Dobrozemsky G et al. In vitro and in vivo evaluation of [(18)F]ciprofloxacin for the imaging of bacterial infections with PET. EurJ Nucl Med Mol Imaging 2005;32:143-50.
108. Palestro CJ, Caprioli R, Love C, Richardson HL, Kipper SL, Weiland FL et al. Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m-labeled monoclonal antigranulocyte antibody. J Foot Ankle Surg 2003;42:2-8. (Pubitemid 36205814)
109. Love C, Tronco GG, Palestro CJ. Imaging of infection and inflammation with 99mTc-Fanplesomab. Q J Nucl Med Mol Imaging 2006;50:113-20.
110. Delcourt A, Huglo D, Prangere T, Benticha H, Devemy F, Tsirtsikoulou D. Comparison between Leukoscan (Sulesomab) and gallium-67 for the diagnosis of osteomyelitis in the diabetic foot. Diabetes Metab 2005;31:125-33. (Pubitemid 40577196)
111. Harwood SJ, Valdivia S, Hung GL, Quenzer RW. Use of sulesomab, a radiolabelled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis 1999;28:1200-5. (Pubitemid 29272790)
112. Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, Israel O.J SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. Nucl Med 2006;47:587-94.
113. Horger M, Eschmann SM, Pfannenberg C, Storek D, Dammann F, Vonthein R et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2003;30:1665-73.
114. Horger M, Eschmann SM, Pfannenberg C, Storek D, Vonthein R, Claussen CD et al. Added value of SPECT/CT in patients suspected of having bone infection: Preliminary results. Arch Orthop Trauma Surg 2007;127:211-21. (Pubitemid 46487097)
115. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 2006;47:1908-13- (Pubitemid 47544977)
116. Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002;21:247-57. (Pubitemid 34507868)
117. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004;31:29-37.
118. Sugawata Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998;25:1238-43.
119. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998;206:749-54.
120. Koort JK, Makinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med 2004;45:1406-11. (Pubitemid 47618542)
121. Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001;42:1551-5.
122. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
123. Israel O, Keidar Z, Iosilevsky G, Bettman L, Sachs J, Frenkel A . The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med 2001;31:191-205.
124. Zhuang H, Duarte PS, Pourdehnad M, Maes A, Van Acker F, Shnier D et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med. 2001;42:44-8.
125. Schwegler B, Stumpe KD, Weishaupt D, Strobel K, Spinas GA, von Schulthess GK et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med 2008;263:99-106.
126. Basu S, Chryssikos T, Houseni M, Scot Malay D, Shah J, Zhuang H et al. Potential role of FDG-PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuropathy from osteomyelitis and soft tissue infection? Nucl Med Commun 2007;28:465-72.
127. Hopfner S, Krolak C, Kessler S, Tiling R, Brinkbäumer K, Hahn K et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int 2004;25:890-5.
128. Dumarey N , Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V et al,Imaging Infection with 18F-FDG Labeled Leukocyte PET/CT: Initial Experience in 21 PatientsJ Nucl Med 2006;47:625-32.